Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
Open Access
- 11 October 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 2342
- https://doi.org/10.3389/fmicb.2019.02342
Abstract
Epidemics of seasonal influenza caused by H1N1pdm09, H3N2, and type B viruses occur throughout the world. Sporadic human H5 and H7N9 virus infections are also reported in particular regions. To treat influenza patients effectively with antivirals, sensitive and broad-reactive influenza rapid diagnostic tests (IRDTs) are required. Here, we tested the sensitivity of 23 IRDTs during the 2018–2019 influenza season for their ability to detect H1N1pdm09, H3N2, H5N1, H5N6, H7N9, and Victoria- and Yamagata-lineage type B viruses. All IRDTs detected all influenza A and B viruses tested but with different sensitivities. Several IRDTs detected the H5 and H7 viruses and the seasonal viruses with similar sensitivity. Such IRDTs might be useful for diagnosing patients infected with H5 and H7 viruses.Funding Information
- Japan Agency for Medical Research and Development
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Agency for Medical Research and Development
- National Institute of Allergy and Infectious Diseases
This publication has 22 references indexed in Scilit:
- Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and MiceJournal of Virology, 2015
- Human Infection with a Novel Avian Influenza A(H5N6) VirusThe New England Journal of Medicine, 2015
- Detection sensitivity of influenza rapid diagnostic testsMicrobiology and Immunology, 2014
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusThe New England Journal of Medicine, 2013
- Viral load and rapid diagnostic test in patients with pandemic H1N1 2009Pediatrics International, 2011
- Laninamivir and its Prodrug, CS-8958: Long-Acting Neuraminidase Inhibitors for the Treatment of InfluenzaAntiviral Chemistry and Chemotherapy, 2010
- Sensitivity of rapid immunoassay for influenza A and B in the early phase of the diseasePediatrics International, 2009
- Nonpharmaceutical Interventions for Pandemic Influenza, International MeasuresEmerging Infectious Diseases, 2006
- Enhanced Expression of an α2,6-Linked Sialic Acid on MDCK Cells Improves Isolation of Human Influenza Viruses and Evaluation of Their Sensitivity to a Neuraminidase InhibitorJournal of Clinical Microbiology, 2005
- Neuraminidase Inhibitors: Zanamivir and OseltamivirAnnals of Pharmacotherapy, 2001